Automated Insulin for Management of Intrapartum Glycemia
NCT: NCT06883344 · RECRUITING
Brief Summary
The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main questions this study aims to answer are * What are the neonatal glycemic outcomes with use of AID systems during labor/delivery? * Do patients report higher birth satisfaction with use of AID systems during labor/delivery? * Are glycemic parameters like time-in-range (TIR) better with use of AID systems during labor/delivery? Researchers will compare AID systems to intravenous (IV) insulin (the current standard of care for glucose management during labor/delivery) by randomly assigning participants to one or the other.
Frequently Asked Questions
What is Automated Insulin for Management of Intrapartum Glycemia?
Automated Insulin for Management of Intrapartum Glycemia is a clinical trial registered under NCT06883344. Current status: RECRUITING.
What is the status of NCT06883344?
The current status of NCT06883344 (Automated Insulin for Management of Intrapartum Glycemia) is: RECRUITING.
When did Automated Insulin for Management of Intrapartum Glycemia start?
Automated Insulin for Management of Intrapartum Glycemia started on 2025-12-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.